Cerium oxide nanoparticles (CeONPs) have received much attention because of their excellent catalytic activities, which are derived from quick and expedient mutation of the oxidation state between Ce4+ and Ce3+. The cerium atom has the ability to easily and drastically adjust its electronic configuration to best fit its immediate environment. It also exhibits oxygen vacancies, or defects, in the lattice structure; these arise through loss of oxygen and/or its electrons, alternating between CeO2 and CeO2−x during redox reactions. Being a mature engineered nanoparticle with various industrial applications, CeONP was recently found to have multi-enzyme, including superoxide oxidase, catalase and oxidase, mimetic properties that produce various biological effects, such as being potentially antioxidant towards almost all noxious intracellular reactive oxygen species. CeONP has emerged as a fascinating and lucrative material in biological fields such as bioanalysis, biomedicine, drug delivery, and bioscaffolding. This review provides a comprehensive introduction to CeONP’s catalytic mechanisms, multi-enzyme-like activities, and potential applications in biological fields.
Rare earth,1 which has been called an ‘industrial vitamin’ and a ‘treasury’ of new materials, has an increasingly important role in technical progress and the development of traditional industries, and it is also widely applied in high-technology industries such as information and biotechnology.2 The chemistry of rare earth differs from main group elements and transition metals because of the nature of the 4f orbitals, which are ‘buried’ inside the atom and are shielded from the atom’s environment by the 4d and 5p electrons.1, 2 These orbitals give rare earth unique catalytic, magnetic and electronic properties. These unusual properties can be exploited to accomplish new types of applications that are not possible with transition and main group metals.
Cerium, which is the first element in the lanthanide group with 4f electrons, has attracted much attention from researchers in physics, chemistry, biology and materials science. When combined with oxygen in a nanoparticle formulation, cerium oxide adopts a fluorite crystalline structure that emerges as a fascinating material.3 This cerium oxide nanoparticle (CeONP) has been used prolifically in various engineering and biological applications, such as solid-oxide fuel cells,4 high-temperature oxidation protection materials,5 catalytic materials,6, 7 solar cells8 and potential pharmacological agents.9 Although useful because of its various properties and applications, the main application of CeONPs is in the field of catalysis, and stems from their unique structure and atomic properties compared with other materials. In recent years, CeONP and CeONP-containing materials have come under intense scrutiny as catalysts and as structural and electronic promoters of heterogeneous catalytic reactions.6 In industry, it has been most widely used as an active component in processes such as three-way catalysts7 for automobile exhaust-gas treatments, oxidative coupling of methane and water-gas shift reaction. Recently, CeONP has been reported to have multi-enzyme, including superoxide oxidase, catalase and oxidase, mimetic properties, and has emerged as a fascinating and lucrative material in biological fields such as in bioanalysis,10, 11, 12, 13, 14, 15 biomedicine,9 drug delivery16, 17 and bioscaffolding.18, 19 This review provides a comprehensive introduction to CeONP’s catalytic mechanisms, multi-enzyme-like activities and potential applications in biological fields.
Synthesis of CeONP
Numerous techniques such as hydrothermal,20 solvothermal,21, 22 aqueous precipitation,23 reversed micelles,24 thermal decomposition25 and flame spray26 methods have been reported to synthesize CeONP, while maintaining control of its size and properties. The synthesized CeONP can be bare or wrapped with a coating of protective substances that can be hydrophilic20 or hydrophobic.22 For biological use, biocompatible CeONP has been systematically synthesized in pure water27 or with the protection of polyethylene glycol,28 dextran,29 polyacrylic acid,10 cyclodextrin,16 glucose17 and so on. Synthetic methods are important because they determine the solubility, size, surface condition, charge, structural arrangement and morphology of nanoparticles, thus affecting their properties, including catalytic activities. One major merit of using nanomaterials is that their properties can be controlled and tailored in a predictable manner to meet the needs of specific applications.
The multi-enzyme mimetic activities of CeONP
The mechanism of the catalytic activity of CeONP
Unlike the other lanthanoid series, which usually exhibit a trivalent (+3) state, the cerium atom can exist in either the +3 (fully reduced) or +4 (fully oxidized) state, because it has two partially filled subshells of electrons, 4f and 5d, with several excited substates predicted.30 In the oxide of cerium, the Ce4+ state with the stable electronic configuration of xenon is preferentially formed. It crystallizes in the fluorite structure in which every cerium atom is surrounded by eight oxygen anions and every oxygen atom occupies a tetrahedral position. Nonetheless, a significant concentration of intrinsic defects is usually present, with a portion of cerium present in the Ce3+ valence state having the deficiency of positive charge compensated by oxygen vacancies.3, 30 The relative amount of cerium ions Ce3+ and Ce4+ is a function of particle size.31 In general, the fraction of Ce3+ ions in the particles increases with decreasing particle size. The techniques used to determine the Ce3+/Ce4+ ratios include X-ray photoelectron spectroscopy,31 X-ray absorption near-edge spectroscopy,32 electron magnetic resonance spectroscopy33 and UV–visible absorption spectroscopy.34
It is remarkable and interesting that CeONP could have a dual role as an oxidation catalyst and reduction catalyst, depending on the reaction conditions. The activities derive from the quick and expedient mutation of the oxidation state between Ce4+ and Ce3+. The cerium atom has the ability to easily and drastically adjust its electronic configuration to best fit its immediate environment.35 It also exhibits oxygen vacancies, or defects, in the lattice structure that arise through loss of oxygen and/or its electrons, alternating between CeO2 and CeO2−x during redox reactions. The Ce4+ and the low formation energies of surface vacancies are important for oxidation, whereas the Ce3+ and electron shuffling within the lattice oxygen vacancies provide power for reduction. Moreover, the addition or removal of oxygen atoms in the oxidizing or reducing process involves a minimal reorganization of the skeleton arrangement of the cerium atoms and the retention of the fluorite structure.35 This structural property facilitates the regenerative ability of CeONP to the initial state and thereby could be recycled to act catalytically.
Strong experimental evidence for the successful shift between Ce4+ and Ce3+ states and the defect structure of CeONP have been provided for the catalytic mechanism.36, 37, 38, 39 Recently, direct observations of atomic-scale surface structures of CeONP have been realized by noncontact atomic force microscopy40, 41 and high-resolution scanning tunneling microscopy.42 The noncontact atomic force microscopy images showed that the hexagonally arranged bright oxygen spots could be observed on the nearly stoichiometric CeO2 (111) surface (Figure 1A), whereas surface oxygen point defects were observed as isolated dark depressions on the reduced CeO2 (111) surface (Figure 1B). When exposed to oxygen atmosphere, the defects could be easily healed (Figure 1C). High-resolution scanning tunneling microscopy studies gave similar results to those of noncontact atomic force microscopy.42 The microscopy images provide direct evidence for the dynamic behavior of surface oxygen atoms of CeONP in different oxidation states, which are important for understanding the role of CeONP in catalysts.
Recently, it was found that CeONP could not only be used as an industrial catalyst, but that it also has multi-bioenzyme mimetic properties.10, 43, 44, 45, 46 Although the mechanisms of these activities were not thoroughly studied and fully understood, one could hypothesize that the properties resemble the mechanism of catalytic activities observed in nonbiological systems. These enzyme-mimetic properties make CeONPs useful in biotechnology and therapeutics.
Superoxide dismutase mimetic activity
Superoxide dismutase (SOD)47 is an enzyme that repairs cells and reduces the damage done to them by superoxide, the most common free radical in the body. It catalyzes the disproportionation of superoxide to H2O2 and O2:
where M=Cu (n=1); Mn (n=2); Fe (n=2); and Ni (n=2).
In this reaction, the oxidation state of the metal cation oscillates between n and n+1. The Ce3+/Ce4+ valence switch ability of CeONP makes it possible for CeONP to be a SOD mimic. Self and colleagues43 evaluated the ability of CeONP to react with superoxide in vitro for the first time. They tested two preparations of CeONP with different Ce3+/Ce4+ ratios and found that CeONP with higher ratios of Ce3+/Ce4+ exhibited a higher SOD-like activity.34, 43 On the basis of the reaction mechanism that is known for SOD, they proposed that the dismutation of superoxide by CeONP is catalyzed as follows:
Celardo et al.9 proposed a more exhaustive molecular mechanism in a later review. As illustrated in Figure 2, using (4) as the original state, superoxide can bind to oxygen vacancy sites around two Ce3+ (5). Next, an electron transfers from one Ce3+ to an oxygen atom. Two protons from the solution can bind to the two electronegative oxygen atoms to form one molecule of H2O2 and be released (6). The remaining oxygen vacancy can provide a binding site for a second superoxide molecule (7). After reaction, a second H2O2 molecule is released and the original 2Ce3+ will be oxidized to 2Ce4+ (1). However, the reaction did not stop with this step. An oxygen vacancy site on the surface (1) presents a 2Ce4+ binding site for one molecule of H2O2 (2); hence, the H2O2 will have the role of a reducing agent. After the release of protons, two electrons will transfer to the two cerium ions to reduce them to 2Ce3+ (3). Next, oxygen is released and the fully reduced oxygen vacancy site returns to the initial state (4). The H2O2 has a paradoxical effect on CeONP for both oxidation and reduction. However, its structural properties allow CeONP to be restored to its initial state.32 The kinetics measured by Seal et al.43 showed excellent activity for CeONP (3–5 nm), with a constant catalytic rate that exceeded the one determined for the enzyme SOD.
Catalase mimetic activity
Catalase48 is a protective enzyme found in nearly all living organisms that are exposed to oxygen. It is responsible for the degradation of H2O2, a powerful and potentially harmful oxidizing agent. Although the complete mechanism of catalase is not currently known, the reaction is believed to occur in two stages:
where Fe(III)-E represents the iron center of the heme group attached to the enzyme and Fe(IV)-E·+ is a mesomeric form of Fe(V)-E.
The catalase-like activity of CeONP was demonstrated by Self and co-workers44 via an Amplex Red assay (Invitrogen, Eugene, OR, USA). CeONP could act as catalase mimic in a redox-state-dependent manner, and higher levels of cerium in the +4 state exhibited more significant activity. These findings are of particular interest, as they are in contrast to CeONP’s SOD mimetic activity, for which lower +3/+4 ratios were found to be less efficient. Celardo et al.9 proposed a possible molecular mechanism involving two half reactions as illustrated in Figure 3. The oxidative half reaction is shown in Figure 3 (1–4). One molecule of H2O2 reacts with Ce4+, reducing it to Ce3+ and releasing protons and O2. The reductive half reaction is shown in Figure 3 (4–6–1). A second H2O2 molecule could bind to the oxygen vacancy site (5), oxidize the Ce3+ back to the initial Ce4+ state and release H2O. The two processes are analogous to the one found in catalases.
It is worth noting that H2O2 was produced when CeONP acted as SOD. In vivo, excess H2O2 is believed to have more toxic potential than superoxide because it is the substrate for the Fenton reaction and generates hydroxyl radicals (OH·), the most destructive reactive oxygen species (ROS).49 Fortunately, CeONP has both catalase- and SOD-like activities. The H2O2 generated in the SOD-mimetic process can enter into the catalase-mimetic dismutation cycle and produce innocuous H2O and O2. This makes CeONP an excellent antioxidant. However, its antioxidative quality is only effective when the two enzyme-like activities of CeONP are coordinated, that is, the H2O2 decomposition rate should be equal to or greater than its generation rate. According to recent reports, many factors such as particle size, Ce3+/Ce4+ ratio,32, 43, 50 buffer species51 and pH conditions51, 52 could affect the enzyme-mimetic properties of CeONP.
The particle size and redox-state-dependent manner have been discussed above. For buffer species, exposure of CeONP to phosphate buffer would result in a decrease in SOD-mimetic activity and an increase in catalase-mimetic activity.51 Given that phosphate is a basic substance in biological systems, its impact on the activity of CeONP should be taken into account when CeONP is used in cell culture or animal studies. However, the ability to reverse the ‘poisoning’ of the SOD-mimetic activity in vivo can be investigated in future studies. The pH value could also influence the catalytic properties of CeONP.51, 52 The catalase-mimetic activity of CeONP under a physiological pH is significantly diminished when under an acidic pH, whereas the SOD activity of CeONP is only slightly affected over a variety of pH changes. This suggests that at a more acidic pH, CeONP cannot detoxify the hydrogen peroxide at the same rate as it can at neutral pH, whereas the rate for superoxide converting to peroxide is not affected. Thus, in an environment with low pH, CeONP could be harmful.
Hydroxyl radical scavenging
The hydroxyl radical (·OH)49 is one of the strongest oxidants and most biologically active free radicals. There are two methods by which living systems remove hydroxyl radicals: blocking hydroxyl radical initiation by antioxidant enzymes (SOD, glutathione peroxidase and catalase) or breaking the hydroxyl radical chain reaction using nonenzymatic antioxidants.49
Hickman and co-workers53 found that ultrafine CeONP (2–5 nm) with mixed valence states had a significant neuroprotective effect on H2O2-treated adult spinal cord model systems designed to prevent oxidative injury. As H2O2 provides a source of hydroxyl radicals, which have a major role in oxidative injury, Hickman and co-workers53 proposed that the protective effect of CeONP on the spinal cord involved its free-radical scavenging effect. Using H2O2 to treat CeONP directly, they observed a significant color change from light yellow to deep orange (Figure 4a), which indicates that Ce3+ (colorless) could be used as an antioxidant to react with the free radicals generated from H2O2 and oxidize to Ce4+ (orange). When the solution was kept in dark conditions for 30 days, the color returned to its original state, which reflected the regeneration of CeONP. Hickman and co-workers53 proposed that the autoregenerative property appears to be the key to CeONP’s neuroprotective action as an antioxidant (Figure 4a). In a later study, Perez et al.29 found that the regenerative ability (or autocatalytic nature) of CeONP was related to the pH environment (Figure 4b). Under physiological (pH 7.4) and basic conditions, the autocatalytic property remained, whereas under acidic conditions, the property was not observed, even when the pH was raised to 7.4. Thus, they revised the reaction equation to make it more reasonable (Figure 4b).
The hydroxyl radical scavenging ability of CeONP elaborated above was inferred from its antioxidant properties. Recently, Xue et al.50 provided direct evidence for the hydroxyl radical scavenging activity of CeONP via a methyl violet assay. They further demonstrated that CeONP could only partly, not completely, eliminate the generated hydroxyl radicals. The activity was also shown to be size dependent and was believed to have a close correlation with Ce3+ at the surface of the particles.
Nitric oxide radical scavenging
The nitric oxide radical (·NO)54 is a gaseous free radical that exhibits multifaceted biological effects, both beneficial and damaging. NO can react rapidly with the superoxide radical, forming the highly reactive peroxynitrite anion (ONOO−), a more powerful and toxic oxidant. A number of disease states are characterized by abnormally high ·NO production, and removing excess ·NO could have salutary effects.
Inspired by CeONP’s NO exhaust gas treatment ability and ·NO adsorption and decomposing ability in industry,55 Self and co-workers56 explored and demonstrated the ·NO scavenging ability of CeONP under physiologically relevant conditions. Surprisingly, compared with the superoxide scavenging properties that prefer a higher level of cerium in the Ce3+ state, the ·NO scavenging ability is present in CeONP with a lower Ce3+/Ce4+ ratio. Similar to the NO dismutation mechanism of iron porphyrins,57 a possible mechanism by which CeONP scavenges NO through formation of an electropositive nitrosyl ligand caused by internal electron transfer from NO to a Ce4+ site was proposed:
Peroxidase mimetic activity
Peroxidases58 are a class of oxidoreductases that are widely distributed among living organisms. They are able to catalyze the reduction of peroxide and oxidize various substrates as follows:
This biochemical function confers on them a role in many different and important biological processes, such as defense mechanisms, immune responses and pathogeny. Peroxidases also occupy a prominent position in biotechnology.58
Recently, many nanomaterials were found to have peroxidase-like activity and the potential to replace nature peroxidase by virtue of their stability, low cost and obtainability.59, 60 For transition metal oxide material-based peroxidase mimics, their activities were mostly derived from the metal ions that have a catalytic activity using H2O2 as substrate through a mechanism similar to that of the Fenton reaction.59 Self and co-workers61 found that cerium ions could also perform a Fenton-like reaction:
This finding gives cerium-containing materials the potential to be used as peroxidase mimics. In a later report, Lv and colleagues45 demonstrated directly that CeONP synthesized by a simple hydrothermal method had a peroxidase-like activity. Furthermore, based on this property the group developed a facile colorimetric method for glucose detection.45 The peroxidase-like activity provides CeONP broad potential applications in environmental chemistry, biotechnology and medicine.
Oxidase mimetic activity
An oxidase62 is an enzyme that catalyzes an oxidation–reduction reaction involving molecular oxygen (O2) as the electron acceptor. The importance of oxidases is emphasized by their multiple physiological roles. Studies by Perez and colleagues10 revealed that CeONP synthesized by an in situ aqueous-phase method showed oxidase-like activities, because they could quickly oxidize several organic substrates without oxidizing agents. In a later study, Gao and colleagues63 proposed that instead of being postulated as oxidase mimic, CeONP was a plain nanoparticulate oxidant and dissolved completely after being reduced under acidic conditions.
Despite these arguments, CeONP used as oxidation catalyst has been widely exploited and has important roles in many fields. For example, in three-way catalysis,7, 64 CeONP catalyzes the conversion of the hydrocarbons, CO and NOx,7, 64 which includes three simultaneous processes:
In the CO and CxH2x+2 oxidation reactions, CeONP has a role similar to oxidase. Regarding the issue of whether CeONP acts directly as an oxidase or an oxidant in organic reagent oxidation, we propose that the role CeONP has may depend on the pH environment. As previously mentioned, under neutral and basic conditions, the Ce4+/Ce3+ recycling ability was maintained, thus providing CeONP catalytic activity, whereas under acidic conditions the recycling ability was not observed. Furthermore, H+ in the acidic solution can react with CeONP to produce dissoluble cerium ions and H2O. Therefore, we deduced that under acidic conditions CeONP acts as a consumable oxidant, whereas under neutral or basic conditions it acts as an oxidase because of the regenerative capacity of the Ce4+ oxidative state. The antioxidant and oxidase activities were not contradictory; rather, they were dependent on the related redox potential of the substrate.
A phosphatase65 is an enzyme that removes phosphate groups from their substrates by hydrolyzing phosphoric acid monoesters into phosphate ions. Phosphates have important roles in many biological processes, including signal transduction and cell proliferation, differentiation, metabolism and communication. Some metal ions and their complexes were reported to be used as artificial phosphoesterases66 that can accelerate the rate of phosphate ester hydrolysis in several ways, including Lewis acid activation, nucleophile activation and leaving group activation. As Lewis acid, some lanthanide ions and their complexes have been shown to be particularly reactive for hydrolyzing phosphate esters.66, 67 Cerium, the only lanthanide that is easily oxidized to the tetravalent state, has received great attention.67
Recent studies have shown that CeONP can hydrolyze phosphate ester bonds of many biologically relevant molecules.46, 68, 69 Qian and colleagues68 found that CeONP could efficiently mediate the dephosphorylation of phosphopeptides. As CeONP is a strong Lewis acid, the dephosphorylation effect can be mainly attributed to Lewis acid activation via coordination of phosphoryl oxygen to Ce4+ and nucleophile activation via coordination of hydroxyl to Ce4+. In addition, CeONP can be regarded as a multinuclear metal–oxygen complex, producing a multiple synergistic activation effect and achieving high catalytic activity. Qian and colleagues68 also proposed several advantages of using CeONP to mediate the dephosphorylation of phosphopeptides. First, it is safe and simple, and can be removed by centrifugation after treatment. Second, its catalytic activity is high. The dephosphorylation of all model phosphopeptides was completed in 10 min. Third, temperature has little effect on the dephosphorylation; hence, precise control of the treatment temperature is not required, which facilitates the treatment process.68
In a later study, Kuchma et al.34 reported that many biologically relevant molecules with phosphate ester, excluding DNA, could be hydrolyzed by CeONP. Interestingly, they observed that unlike the single nuclear complexes of cerium, the dephosphorylative activity of CeONP depends on the presence of Ce3+ sites and is inhibited when Ce3+ is converted to Ce4+. This is contrary to the opinions of Qian and colleagues68 who proposed a Ce4+-mediated hydrolysis process. To fully understand the mechanism, additional research must be carried out.
Nanotechnology has already greatly impacted bioanalysis.70 The stable physical and chemical properties make inorganic nanoparticles suitable for use in biological assays to eliminate the shortcomings of organic fluorophores, radioactive labeling or natural enzymes, which are photobleachable, toxic, and expensive and easily degradable, respectively.70 These multi-enzyme-like properties have been successfully used for biological detection and analysis.
On the basis of the oxidase-like activity of CeONP, which facilitated the oxidation of organic molecules to yield chromogenic products, Perez and colleagues10 developed robust and reliable colorimetric immunoassays (Figure 5A). They attached folic acid to polyacrylic acid-coated CeONP (PNC) via click chemistry. As folic acid can specifically recognize certain tumor cells with elevated expression of folate receptors on the surface, it could be used instead of the antifolate receptor antibody traditionally used in enzyme-linked immunosorbent assay (ELISA). Target cancer cells (such as lung carcinoma cell line, A-549) would capture the folic-acid-modified PNC. Using 3,3′,5,5′-tetramethylbenzidine as the reporting substrate, a colorimetric assay could be established. The efficiency was judged by the increase in absorbance at 652 nm with increasing amounts of A-549 cells. Using cardiac myocytes (H9c2) cells, which have no folate receptors, as a control, the results showed negligible absorbance changes and thus demonstrated selectivity. The device performed best under acidic conditions. A traditional ELISA assay was also carried out using horseradish peroxidase-labeled secondary antibodies to assess the binding of a specific primary antibody to a particular target or surface receptor and evaluated by catalyzing the oxidation of 3,3′,5,5′-tetramethylbenzidine by H2O2. Perez and colleagues10 compared CeONP-based ELISA assay with the traditional ELISA assay and found that the CeONP had several advantages: (1) both the antibody and natural enzyme (horseradish peroxidase) used in traditional ELISA assay were unstable and easy to denature and inactivate, whereas the folic acid and nanoenzyme CeONP used in CeONP-based ELISA assay were more stable; (2) the H2O2 used in traditional ELISA assay for horseradish peroxidase can easily decompose and lose its oxidative ability, whereas CeONP could oxidize the substrate without H2O2, thus eliminating the problem; and (3) the cost of the CeONP method is much lower and the operation is much easier, making it more robust than the traditional ELISA assay.
As the CeONP-based ELISA assay described above is optimal under acidic conditions, which limits the use of antibodies and other pH-labile biomolecules as targeting ligands, Perez and colleagues11 improved it by exploiting a milder method that could be used under neutral conditions (Figure 5B). They used the fluorescent molecule Ampliflu as the reporter molecule instead of 3,3′,5,5′-tetramethylbenzidine. Ampliflu could be oxidized to fluorescent resorufin by weak oxidase activity, whereas the strong oxidase activity of CeONP would trigger complete oxidation to the nonfluorescent resazurin. As the oxidase-like activity of CeONP is pH dependent and has a mild activity at neutral pH, CeONP could facilitate the partial oxidation of Ampliflu to the fluorescent resorufin. The method was also used to detect folate-receptor-expressed cancer cells using protein G and antifolate-receptor antibody co-modified CeONP. The assay is faster and cheaper than traditional ELISA assay and is expected to be used in the clinic.
The combination of oxidase-like and phosphatase-like activities
Qu and colleagues71 reported that nucleoside triphosphates (NTPs) can improve the oxidase-like activity of CeONP and that the enhancement is correlated with the type of NTPs (Figure 5C). This effect was demonstrated to be a result of the coupling of the oxidative reaction with the NTPs’ hydrolysis reactions, because CeONP has both oxidase-like and phosphatase-like activities. Unlike when NTPs, acting as coenzymes for biological enzymes, undergo hydrolysis assisted by metal ions as catalysts, in this reaction the hydrolysis of the NTPs could be catalyzed in situ by CeONP, which is attributed to its inherent phosphatase-like activity. The energies released from the NTP hydrolysis can further improve the oxidase-like activity of CeONP. Moreover, the catalytic ability of CeONP in NTP hydrolysis is correlated with the type of NTP, which then leads to different improving efficiencies of NTP for the oxidase activity of CeONP. On the basis of the NTP-promoted oxidase-like activity of CeONP and the differences among the various NTPs, Perez and colleagues11 developed series-effective colorimetric assays for genotyping (identification of the types of mismatched bases) of single-nucleotide polymorphisms.
pH-dependent bioenzyme mimetic activities
Perez and colleagues13 also reported a CeONP-based device for the detection of chronic inflammation by optical and magnetic resonance imaging. Chronic inflammatory conditions are usually associated with high local concentrations of ROS (for example, H2O2) and decreases in pH, which could be used as pro-inflammatory markers. Taking advantage of the pH-dependent antioxidant activities, Perez’s group used CeONP as a sensor for ROS and pH conditions, and visualized these environmental alterations using multimodal iron oxide nanoparticles. They co-encased polyacrylic acid-coated CeONP (PNC) and near-infrared light-emitting carbocyanine DilC18(7)-encapsulating dextran-coated iron oxide nanoparticles in a fabricated device (Figure 6A). Under physiological conditions, CeONP could protect the DilC18(7) from fluorescence quenching caused by traces of extracellular ROS. However, in conditions simulating chronic inflammation where the levels of ROS are high and the extracellular milieu’s pH drops, CeONP was not able to protect the carbocyanine DilC18(7) from oxidation-induced quenching, resulting in marked decreases in the device’s fluorescence emission. However, the magnetic resonance imaging signal (T2) of iron oxide nanoparticles increased, which was caused by the ROS-induced polymerization of the nanoparticles’ dextran coating under low pH values being catalyzed by the particles themselves. The device was able to distinguish physiological from abnormal ROS and pH levels (Figure 6A); thus, it could have applications for a broad range of diseases that have a proinflammatory component.
Li et al.12 found that PNC can facilitate the fast oxidation of luminol by H2O2 and greatly enhance the chemiluminescence intensity of this system. On the basis of this, they designed a sandwich method for detection of human thrombin. They immobilized the thrombin aptamer onto a magnetic bead for specific thrombin capture. Au nanoparticles containing bio-bar-coded PNC and reporter DNA complementary to thrombin aptamer were used as amplified labels, and luminol–H2O2–PNC was employed as a reporter system. The use of PNC for the direct catalysis of the luminol–H2O2 system avoided poisoning by HBr/Br2 or HNO3 solution, which are generally used in other analysis. The PNC’s ability to act as catalyst in the luminol–H2O2 system contributed to its peroxidase-like activity.
As well as catalyzing the colorimetric reactions of organic dyes, CeONP could also be used as a colorimetric agent itself by virtue of its color-changing ability corresponding with a shift in redox state.29, 53 Taking advantage of this, Andreescu and colleagues14 described a novel concept using CeONP as a chromogenic component for colorimetric paper bioassays. The core principle of the bioassay was an H2O2-induced redox state shift of surface cerium ions from Ce3+ to Ce4+ species in CeONP that was accompanied by visible color changes from white-yellowish to dark orange.29, 53 Thus, it could be used for H2O2-related molecular analysis. Using glucose as a model analyte, Andreescu and colleagues14 co-immobilized CeONP and glucose oxidase onto filter paper by a silanization procedure to construct a glucose-sensing paper. The assay is fully reversible and can be reused for multiple cycles. The reversible process takes place gradually over several days at room temperature or within several minutes by slight heating. The study provides a new nanoparticle platform for the fabrication of paper-based colorimetric bioassays.
On the basis of the H2O2-induced color changing and regenerative capability of CeONP, Lin et al.15 constructed a novel resettable and colorimetric logic network by using CeONP as a signal transducer (Figure 6B). The CeONP solution is nearly colorless, whereas the addition of H2O2 causes an instantaneous color change to yellow. They defined the yellow solution as ON state (1) and the colorless solution as OFF state (0). As H2O2 is a common product of oxidative metabolism in living organisms, it can be generated by various types of enzymatic cascade cycles. Thus, Lin et al.15 combined the H2O2-responsive CeONP and biocatalytic reactions to construct robust logic gates (Figure 6B). They designed multiple input signal systems and demonstrated that these systems could be scaled up to perform large network-mimicking natural biochemical pathways. The regenerative capability of CeONP made the logic gates feasible to reset to their initial conditions by heating. This CeONP-based logic gate solved the two major problems of chemical computing systems72: (1) difficult to scale up for assembling large networking systems because of the interference between reactions and the incompatibility of various chemical gates operating under different conditions; (2) unable to realize the logic system reset, which is a crucial property for practical applications. Finally, Lin et al.15 applied the proposed system in practical logic sensing. Compared with traditional sensing devices, logic biosensors are able to intelligently analyze the relationship between different targets. This logic system has potential applications in the field of intelligent diagnostics.
Cerium compound applications in biomedicine
The pharmacological properties of cerium were discovered more than a century ago and have been used to treat many types of diseases.73 Cerium(III) oxalate has been widely used to treat vomiting-related diseases such as pregnancy, sea-sickness, chronic diarrhea and neurological disorders, including epilepsy and chorea.74 Cerium nitrate is available as an adjunct to silver sulfadiazine cream for the topical treatment of extensive burns.75 According to clinical reports from the pioneering era of cancer chemotherapy, cerium(III) iodide could cause tumor shrinkage and improved quality of life.76 These diverse biomedical effects contributed to the biorelated properties of cerium, such as a resemblance to calcium, bacteriostatic and bactericidal activities, and immunomodulatory properties.73
Although the cerium compounds have the potential to be used in biomedicine, there are many drawbacks: (1) small molecule drugs cannot be easily taken up directly by cells; (2) the short blood circulation time and nonspecific biodistribution of cerium compounds would cause many unwanted side effects; and (3) many cerium compounds, such as cerium oxalate, are nearly insoluble in water, which makes their absorption by organisms difficult. Nanostructured materials can be employed to overcome these limitations, because they can be taken up by mammalian cells easily through many pathways. Being easy to modify and having long blood circulation times make nanostructured materials potentially targetable with a controllable distribution in vivo. In addition, the insolubility could be easily solved by wrapping the material in a layer of water-soluble polymers. The pharmacological potentials of CeONP for many diseases has increased in recent years.9, 77
Oxidative stress-related diseases
Oxidative stress78 in biological systems results from an imbalance between ROS and nitrogen species production and antioxidant levels. ROS and reactive nitrogen species are potent oxidizing and nitrating agents that include O, ·HO, H2O2, ·NO and ONOO−. These reactive species are normal byproducts and have dual roles in the organism, causing toxicity or acting as signaling molecules, depending on concentration, location and intracellular conditions.78 In normal biological systems, when excess reactive species are produced to a limited degree, cells are able to counteract the damage through innate mechanisms, including enzyme antioxidants and endogenous reductants. However, when the production of reactive species exceeds the capacity of cellular defense systems or when cell defense systems are compromised by aging or diseases, problems can arise. Such aberrant active species can cause substantial damage, or oxidative stress, to molecular structures in biological organisms. Oxidative stress has a role in aging and in a variety of human disease states, such as inflammatory and autoimmune diseases, arthritis, cardiovascular disease and neurodegenerative disorders.
Because of its multiple antioxidant-enzyme-like activities, including SOD, catalase, peroxidase-like activities, and hydroxyl radical and nitric oxide radical scavenging properties, CeONP was expected to scavenge almost all types of reactive species. This makes it superior to any antioxidant enzyme or molecule because they often scavenge only a single type of free radical before being inactivated. Recently, CeONP has been receiving much attention as a potential antioxidant agent in vivo and as a potential therapeutic tool in the treatment of oxidative-stress-related diseases.
Neurodegenerative disorders. Being the most active organ in the body, the brain and central nervous system are particularly susceptible to oxidative stress because of high oxygen utilization, low levels of endogenous antioxidant systems and high levels of polyunsaturated fatty acids, which are subject to lipid peroxidation.79 Increased oxidative stress and free radical production are associated with several neurodegenerative diseases, such as trauma, Alzheimer’s disease (AD) and Parkinson’s diseases, ischemic stroke and aging.80 Therapeutic efforts aimed at the removal of ROS or prevention of their formation are considered to be beneficial in neurodegenerative diseases. However, use of molecular antioxidants in abolishing these pathological conditions has thus far met with only limited success, which was attributed to the limits of molecular antioxidants: (1) they are not easily taken up directly by cells, which results in an inability to achieve satisfactory levels of antioxidants at the site of injury; (2) many can scavenge only one type of reactive species, whereas diseases often generate mixed reactive species of more than one type; and (3) they cannot cross the blood–brain barrier (BBB).81 Therefore, there is an urgent need to design novel classes of antioxidants that are superior to molecular antioxidants. Special attention has been paid to CeONP as an antioxidant, because it can scavenge almost all types of reactive species, has excellent regeneration ability and can cross the BBB because of its nano size.82
Recently, CeONP has been demonstrated to successfully protect neurons from free-radical-mediated damage initiated by UV light, H2O2, irradiation and excitotoxicity.83, 84, 85, 86 Schubert et al.85 reported protection from exogenous oxidants in a neuronal cell line (HT22) in the presence of CeONP and yttrium oxide nanoparticles. Das and colleagues86 reported that CeONP provides a significant neuroprotective effect on adult rat spinal cords against H2O2. CeONP can also prolong the lifespan of healthy cortical brain cells by about up to sixfold.83, 84 Inspired by these neutron-protective effects, the application of CeONP for treatment of neurodegenerative disorder-related diseases was studied and promising results were obtained.
D'Angelo et al.87 investigated the effects of CeONP protection of neuronal cells against cell death induced by Alzheimer’s injury on an in vitro human AD model. AD is the most common neurodegenerative disorder and the primary cause of dementia in the elderly. It is characterized by cerebral extracellular amyloid plaques and intracellular neurofibrillary tangles formed by polymerization of amyloid β-peptides (Aβ).88 It is associated with multiple etiologies and pathogenic mechanisms, and Aβ-associated free radicals and the resultant oxidative stress are an important part of the mechanism that is involved in the pathogenic cascade.89 Barbara et al. established the AD model by the Aβ-treated differentiated SH-SY5Y human neuroblastoma cells. The Aβ-treated cells showed evident morphological alterations and axonal and dendritic dystrophy. However, incubation with CeONP protected cell viability and cell morphology from Aβ injury. Barbara et al. demonstrated that CeONP acted not only as a mere antioxidant agent but also as a modulator of signal transduction pathways for neuronal survival.
Subsequently, Cimini et al.90 developed an anti-amyloid β-antibody-conjugated CeONP to enhance its specific target to Aβ aggregates. They synthesized polyethylene glycol-coated CeONP and subsequently conjugated anti-amyloid β-antibody to it (anti-Aβ–CEONP–polyethylene glycol). The results showed that the conjugation could be selectively delivered to the Aβ plaques and there was a concomitant increase in neuronal survival (Figure 7A). This anti-Aβ–CeONP conjugation may be a potential candidate for antineurodegenerative therapy in vivo.
Kim et al.91 reported that CeONP can protect against ischemic stroke. Cerebral ischemia, or stroke, caused by a reduction of blood flow to the brain because of a clot or hemorrhage is the third leading cause of death worldwide. The lack of energy production that occurs as a result of the reduction in glucose and oxygen delivery to brain cells could lead to a disruption in ionic homeostasis and consequently induces excitotoxicity, oxidative stress, inflammation, BBB dysfunction and, ultimately, cell death. Kim et al.91 synthesized CeONP and encapsulated it with phospholipid–polyethylene glycol to enable longer circulation in the bloodstream by reducing nonspecific binding and uptake by organs. They demonstrated that CeONP could reduce ROS-induced cell death in vitro by using tert-butyl hydroperoxide treated CHO-K1 cells. They further demonstrated this protective effect in living animal models (rats) with ischemic stroke. CeONP can reduce apoptotic cell death by decreasing ROS, which leads to a decreased infarct volume (Figure 7B).
Diabetes. Diabetes mellitus is a metabolic disorder characterized by hyperglycemia and insufficient secretion or action of endogenous insulin.92 Increased oxidative stress is a widely accepted participant in the development and progression of diabetes and its complications.92 Abdollahi and colleagues93 found that the combination of CeONP and sodium selenium was beneficial to diabetic rats. The weight of diabetic rats decreased significantly and blood glucose increased significantly compared with that in control rats. After treatment with the combination of sodium selenite and CeONP, a significant increase in weight and a significant decrease in blood glucose were shown. An improvement in biomarkers of diabetes, including oxidative stress, energy compensation (ADP/ATP), lipid profile and hepatic ROS levels, was also observed. This benefit effect was attributed to the synergistic antioxidant effect of CeONP and selenium.
Abdollahi and colleagues94 then reported that CeONP–sodium selenite combination could also improve pancreatic islet function during isolation and transplantation procedures. Patients with insulin-dependent diabetes mellitus require persistent insulin therapy, but pancreatic islet transplantation is usually the final cure that is needed in most cases. Despite recent improvements, islets of Langerhans experience excessive oxidative stress during isolation and transplantation procedures. Pretreatment with a CeONP–sodium selenite combination showed a significant increase in viability, secretion of insulin and ATP/ADP ratio, and a decrease in ROS levels in isolated, cultured pancreatic islets.
Retinal damage (retinal diseases). Photoreceptor cells have the highest rate of oxygen metabolism of any cells in the body and are continuously exposed to the deleterious effects of oxidative stress and constant bombardment by photons. The ROS that damage the sensitive cells in the retina are thought to have a central role in retinal diseases, including inherited retinal degeneration, diabetic retinopathy, macular degeneration and retinal detachment, which could lead to partial or complete loss of vision.95 McGinnis and co-workers96 demonstrated for the first time that CeONP could prevent retinal degeneration induced by intracellular peroxides and thus preserve retinal morphology and prevent loss of retinal function by using in vitro cell culture system and an in vivo albino rat light-damage model (Figure 7C). Next, they explored the mechanism further by using the homozygous tubby mutant mouse as a model, which exhibits inherited early progressive cochlear and retinal degeneration.97, 98 McGinnis and co-workers demonstrated that CeONP protects the retina by decreasing ROS, upregulating the expression of neuroprotection-associated genes, downregulating apoptosis signaling pathways and/or upregulating survival signaling pathways to slow photoreceptor degeneration. In a specific age-related macular degeneration model, Zhou et al.99 found that CeONP could inhibit rises in ROS, increases in vascular endothelial growth factor in the photoreceptor layer and the formation of intraretinal and subretinal neovascular lesions. CeONP could also induce the regression of pre-existing pathologic retinal neovasculature.
Chronic inflammation. Chronic inflammation is a complex immunological disorder that can result in irreversible organ damage, and often precedes and promotes the development of many major diseases.100 Overproduction of the free radical nitric oxide (·NO) has been implicated as a critical mediator of inflammation. The ability of CeONP to scavenge ·NO makes it a potential anti-inflammatory agent. Hirst et al.27 reported that CeONP could inhibit inflammatory mediator production in J774A.1 murine macrophages. In vivo studies also showed good biocompatibility of CeONP; it could be deposited in mouse tissues with no pathogenicity, and was well tolerated and incorporated into cellular tissues.
These studies suggest that CeONP has significant potential for therapeutic treatment of most types of oxidative-stress-related diseases.
Previous studies have shown that CeONP is cytotoxic to cancer cells, inducing oxidative stress and causing lipid peroxidation and cell membrane leakage.101 It is also reported to protect normal cells but not cancer cells from ROS damage.29 This may be attributed to cancer cells having a more acidic cytosolic pH than normal cells because of higher glycolysis and significantly higher production of lactate.102 As previously mentioned, in acidic conditions, the antioxidant ability of CeONP is lost and it behaves as a strong oxidant, which may facilitate the oxidation of intracellular and extracellular components to induce cell apoptosis. CeONP was also reported to manipulate tumor–stromal interactions to detract tumor progression and invasion while benefiting stromal cells,103 which was attributed to the bifunctional character of CeONP. The cytosolic pH environments of stromal cells (for example, fibroblasts) are neutral; thus, CeONP would behave as an antioxidant to scavenge the ROS. Although epithelial/stromal signaling is largely mediated by myofibroblasts, and ROS have an important role in trigger mesenchymal–mesenchymal transition of human dermal fibroblasts to myofibroblasts, treatment with CeONP would downregulate the expression of myofibroblastic cells and inhibit the tumor invasion. Taken together, CeONP has both direct cytotoxicity and indirect anti-invasive properties on tumor cells.
Furthermore, CeONP is also shown to confer radioprotection to normal cells while increasing toxicity to cancer cells,104, 105, 106, 107 which is significant in radiation therapy (RT). Although RT remains an effective modality for the control and cure of malignant cancer, many harmful side effects are associated with it, including fatigue, nausea and dermatitis. Many recent research studies have been focused on the alleviation of radiation damage on surrounding healthy cells. Amifostine108 is the only clinically available radioprotectant, even though it can cause nausea and hypotension. The bifunctional character of CeONP gives it the potential to be used as an adjuvant for RT. Several publications have shown that treatment with CeONP before RT exposure decreases the RT-induced cell damage and death in normal tissues of the gastrointestinal tract,104 lung,105 breast,106 and head and neck.107 Conversely, CeONP could enhance the efficiency of RT to induce tumor cell death because of its acidic cytosolic environment.106, 107
Drug delivery devices and bioscaffold
Recently, nanoparticles have shown tremendous potential use in biotechnology as drug delivery systems and bioscaffolds. CeONP, a nanomaterial with pharmacological potential, could be used as a nanocarrier or scaffold and also act as a therapeutic agent. Combining the two properties increases CeONP’s potential application in biotechnology.
Drug delivery devices
Inspired by the distinctive and multifaceted properties of CeONP, a multifunctional CeONP-capped mesoporous silica nanoparticle (MSN) anticancer drug delivery system was designed by Qu and colleagues16 (Figure 8A). They synthesized β-cyclodextrin-modified CeONP and ferrocene-functionalized MSN. Under physiological conditions, β-cyclodextrin-modified CeONP could cap onto ferrocene-functionalized MSN through host–guest interactions between β-CD and ferrocene. After internalization into lung carcinoma (A549) cells by a lysosomal pathway (pH≈4.5–5.0), the ferrocenyl moieties were oxidized to ferrocenium ions by CeONP lids, which triggered the uncapping of CeONP and caused the drug release. Because of the cytotoxicity of CeONP under acidic conditions, it exhibited a synergistic antitumor effect with the antitumor drugs. Furthermore, because of its antioxidant properties in physiological environments, CeONP would be beneficial in the next metabolic process. The multifunctional properties made CeONP an attractive drug delivery material.
By using the neuroprotection property and neurodegenerative disorder treatment ability of CeONP, Qu and colleagues17 reported a CeONP-capped, H2O2-responsive drug release system for AD treatment (Figure 8B). Orthodox metal chelators were developed to be used as therapeutic agents for AD to alleviate the metal-related toxicity. However, their applications were restricted by the poor BBB permeability and low inhibition efficiency. To this end, the authors intended to load metal chelators in a phenylboronic acid-functionalized MSN carrier sealed with glucose-coated CeONP through a unique covalent reaction of phenylboronic acid and glucose to form cyclic boronate moieties.17 The designed delivery platform could cross the BBB. The cyclic boronate moieties could be broken in the presence of H2O2 produced by Aβ aggregate metal ions, resulting in the release of CeONP and the guest molecules, which indicated that the platform could realize targeted drug delivery. Their design combined the anti-aggregation property of metal chelators and anti-oxidant property of CeONP in one system. This two-in-one bifunctional platform could effectively inhibit Aβ aggregate formation, decrease cellular ROS and protect cells from Aβ-related toxicity (Figure 8B).
Seal and co-workers18 reported that CeONP could increase the production of collagen by human mesenchymal stem cells (HMSCs) cultured on porous bioactive glass scaffolds. Porous bioactive glass scaffolds, which have been used clinically, can bind to bone and act as a temporary guide and stimulus for bone growth in three dimensions. Bone-marrow-derived HMSCs line is a crucial cell type for bone regeneration in vivo, because they differentiate to osteoprogenitor cells. It is reported that HMSCs are sensitive to toxic compounds derived from molecular oxygen. CeONP can increase the proliferation of HMSCs by neutralizing oxidative stress. Thus, embedding CeONP into porous three dimensional bioactive glass foam scaffolds could enhance osteoblastic differentiation of HMSCs and collagen formation.
By mixing CeONP powder and poly(D,L-lactic-co-glycolic acid) at specific concentrations followed by solvent casting onto prepatterned molds, Mandoli et al.19 fabricated hybrid two dimensional polymeric–ceramic biosupports for stem cells culturing in vitro. CeONP not only improved the polymer-based composite mechanical properties but also stimulated the regenerating tissue biochemical activity, contributing to its antioxidant activity. The effect of CeONP on the biological response might be ascribed either to the chemical nature of CeONP or from the physical and morphological changes in roughness and stiffness brought to the composite scaffolds (Figure 9). These findings showed that hybrid ceramic polymeric bioactive scaffolds loaded with CeONP hold great potential for tissue engineering applications.
The toxicological effects of CeONP
Being a nanomaterial with numerous potential biological applications, the toxicological effects of CeONP have attracted more and more attention. A variety of in vitro and in vivo studies were carried out, and the results showed controversial conclusions.
In vitro studies
CeONP could be successful uptaken by mammalian cells in both normal and diseased states through multiple routes.77 In most cases of in vitro intracellular assays, CeONP was reported to exhibit positive effects (such as scavenging ROS) and was regarded as a promising biomaterial for biomedical applications.9 However, several reports suggested that the uptake of CeONP could induce oxidative stress and DNA damage, dephosphorylation of various substrates, aberrant cell signaling and alterations in the transcriptional and posttranslational levels.109, 110, 111 The cell lines used in the published studies established cell lines and primary cultures from tumors or normal tissues, which has been thoroughly reviewed in the literature. Although it was recently demonstrated that localization of CeONP in acidified lysosomes induced cell death111 and that CeONP could induce cytotoxicity through autophagy and a mitochondrial apoptosis pathway,110 simple correlations of the cytotoxicity effect of CeONP with cell types or particle size/preparations has not been established.112
In vivo studies
In vivo analyses of the biological effect of CeONP were carried out by peroral, intravenous or intraperitoneal administration to laboratory animals. It was reported that using CeONP as a food additive could increase the average and maximum lifespan of Drosophila.84 The potential pharmacological activity of CeONP has also been evaluated. It was shown that CeONP could prevent retinal degeneration induced by intracellular peroxides96 and could relieve the symptoms of ischemic stroke,91 ischemic cardiomyopathy,113 diabetes,93 radiation-induced pneumonitis105 and lupus84 in animal models of disease. These effects mainly depended on the ROS scavenging ability of CeONP. However, there were still a few studies showing that exposure of animals to CeONP resulted in significant lung responses, including lung inflammation, cytotoxicity, lung injury, alveolar macrophage functional changes, induction of phospholipidosis and release of pro-inflammatory and fibrotic cytokines.114 Cerium is also linked to fibrosis of the heart, and CeONP was shown to induce myocardial fibroblast proliferation and collagen deposition in rats.115 In addition, as cerium is not found in the human body and there are no clearance mechanisms for it, systemic toxicity would be the result.
Conclusions and perspectives
Derived from quick and expedient mutations of the oxidation state between Ce4+ and Ce3+, CeONP has excellent catalytic and multi-enzyme-mimetic properties. These make it attractive for widespread applications, both in industry and in biosystems. At present, the industrial applications of CeONP are well developed, whereas bio-applications are still in their infancy. Numerous studies have reported enzyme-like activities of CeONP, the results of which were supported by abiotic studies in simple buffer solutions; however, they must be demonstrated and investigated further in biological media, cells, tissues and even animals. In addition, there are divergent biological effects obtained with CeONP, with it being beneficial in one case and toxic in another. Thus, the toxic mechanism should be carefully and systematically investigated with animal models over long periods of time, and comprehensive investigative methods must be developed. It is also worth noting that the CeONP used in the investigations were not consist in preparation, particle size or surface characteristic, even though these features may have important role in CeONP’s biological reactivity/toxicology. Unfortunately, until recently, information about the relationships between the properties of CeONP was fragmented and vague. Further systematic investigations are required.
Although there are still some unresolved issues and challenges, the unique physical and chemical properties of CeONP and the achieved significant advances of it clearly demonstrate that CeONP is a fascinating and versatile material that is promising for numerous industrial and biomedical applications.
Hu, Z., Haneklaus, S., Sparovek, G. & Schnug, E. Rare earth elements in soils. Commun. Soil Sci. Plant. Anal. 37, 1381–1420 (2006).
Bouzigues, C., Gacoin, T. & Alexandrou, A. Biological applications of rare-earth based nanoparticles. Acs Nano 5, 8488–8505 (2011).
Conesa, J. C. computer modeling of surfaces and defects on cerium dioxide. Surf. Sci. 339, 337–352 (1995).
Stambouli, A. B. & Traversa, E. Solid oxide fuel cells (SOFCs): a review of an environmentally clean and efficient source of energy. Renew. Sust. Energ. Rev. 6, 433–455 (2002).
Patil, S., Kuiry, S. C., Seal, S. & Vanfleet, R. Synthesis of nanocrystalline ceria particles for high temperature oxidation resistant coating. J. Nanopart. Res. 4, 433–438 (2002).
Trovarelli, A. Catalytic properties of ceria and CeO2-containing materials. Catal. Rev. 38, 439–520 (1996).
Kaspar, J., Fornasiero, P. & Graziani, M. Use of CeO2-based oxides in the three-way catalysis. Catal. Today 50, 285–298 (1999).
Corma, A., Atienzar, P., Garcia, H. & Chane-Ching, J. Y. Hierarchically mesostructured doped CeO2 with potential for solar-cell use. Nat. Mater. 3, 394–397 (2004).
Celardo, I., Pedersen, J. Z., Traversa, E. & Ghibelli, L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale 3, 1411–1420 (2011).
Asati, A., Santra, S., Kaittanis, C., Nath, S. & Perez, J. M. Oxidase-like activity of polymer-coated cerium oxide nanoparticles. Angew. Chem. Int. Ed. 48, 2308–2312 (2009).
Asati, A., Kaittanis, C., Santra, S. & Perez, J. M. pH-tunable oxidase-like activity of cerium oxide nanoparticles achieving sensitive fluorigenic detection of cancer biomarkers at neutral pH. Anal. Chem. 83, 2547–2553 (2011).
Li, X., Sun, L., Ge, A. & Guo, Y. Enhanced chemiluminescence detection of thrombin based on cerium oxide nanoparticles. Chem. Commun. 47, 947–949 (2011).
Kaittanis, C., Santra, S., Asati, A. & Perez, J. M. A cerium oxide nanoparticle-based device for the detection of chronic inflammation via optical and magnetic resonance imaging. Nanoscale 2117–2123 (2012).
Ornatska, M., Sharpe, E., Andreescu, D. & Andreescu, S. Paper bioassay based on ceria nanoparticles as colorimetric probes. Anal. Chem. 83, 4273–4280 (2011).
Lin, Y. H., Xu, C., Ren, J. S. & Qu, X. G. Using thermally regenerable cerium oxide nanoparticles in biocomputing to perform label-free, resettable, and colorimetric logic operations. Angew. Chem. Int. Ed. 51, 12579–12583 (2012).
Xu, C., Lin, Y., Wang, J., Wu, L., Wei, W., Ren, J. & Qu, X. Nanoceria-triggered synergetic drug release based on CeO2-capped mesoporous silica host–guest interactions and switchable enzymatic activity and cellular effects of CeO2 . Adv. Healthcare Mater. 2, 1591–1599 (2013).
Li, M., Shi, P., Xu, C., Ren, J. S. & Qu, X. G. Cerium oxide caged metal chelator: anti-aggregation and anti-oxidation integrated H2O2-responsive controlled drug release for potential Alzheimer’s disease treatment. Chem. Sci. 4, 2536–2542 (2013).
Karakoti, A. S., Tsigkou, O., Yue, S., Lee, P. D., Stevens, M. M., Jones, J. R. & Seal, S. Rare earth oxides as nanoadditives in 3-D nanocomposite scaffolds for bone regeneration. J. Mater. Chem. 20, 8912–8919 (2010).
Mandoli, C., Pagliari, F., Pagliari, S., Forte, G., Di Nardo, P., Licoccia, S. & Traversa, E. Stem cell aligned growth induced by CeO2 nanoparticles in PLGA scaffolds with improved bioactivity for regenerative medicine. Adv. Funct. Mater. 20, 1617–1624 (2010).
Yu, S. H., Colfen, H. & Fischer, A. High quality CeO2 nanocrystals stabilized by a double hydrophilic block copolymer. Colloid Surf. A 234, 49–52 (2004).
Inoue, M., Kimura, M. & Inui, T. Transparent colloidal solution of 2 nm ceria particles. Chem. Commun. 957–958 (1999).
Gu, H. & Soucek, M. D. Preparation and characterization of monodisperse cerium oxide nanoparticles in hydrocarbon solvents. Chem. Mater. 19, 1103–1110 (2007).
Sreeremya, T. S., Thulasi, K. M., Krishnan, A. & Ghosh, S. A novel aqueous route to fabricate ultrasmall monodisperse lipophilic cerium oxide nanoparticles. Ind. Eng. Chem. Res. 51, 318–326 (2012).
Sathyamurthy, S., Leonard, K. J., Dabestani, R. T. & Paranthaman, M. P. Reverse micellar synthesis of cerium oxide nanoparticles. Nanotechnology 16, 1960–1964 (2005).
Lin, H. L., Wu, C. Y. & Chiang, R. K. Facile synthesis of CeO2 nanoplates and nanorods by  oriented growth. J. Colloid Interf. Sci. 341, 12–17 (2010).
Madler, L., Stark, W. J. & Pratsinis, S. E. Flame-made ceria nanoparticles. J. Mater. Res. 17, 1356–1362 (2002).
Hirst, S. M., Karakoti, A. S., Tyler, R. D., Sriranganathan, N., Seal, S. & Reilly, C. M. Anti-inflammatory properties of cerium oxide nanoparticles. Small 24, 2848–2856 (2009).
Karakoti, A. S., Singh, S., Kumar, A., Malinska, M., Kuchibhatla, S. V. N. T., Wozniak, K., Self, W. T. & Seal, S. PEGylated nanoceria as radical scavenger with tunable redox chemistry. J. Am. Chem. Soc. 131, 14144–14145 (2009).
Perez, J. M., Asati, A., Nath, S. & Kaittanis, C. Synthesis of biocompatible dextran-coated nanoceria with pH-dependent antioxidant properties. Small 4, 552–556 (2008).
Suzuki, T., Kosacki, I., Anderson, H. U. & Colomban, P. Electrical conductivity and lattice defects in nanocrystalline cerium oxide thin films. J. Am. Ceram. Soc. 84, 2007–2014 (2001).
Zhang, F., Chen, C.-H., Raitano, J. M., Hanson, J. C., Caliebe, W. A., Khalid, S. & Chan, S.-W. Phase stability in ceria-zirconia binary oxide nanoparticles: the effect of the Ce3+ concentration and the redox environment. J. Appl. Phys. 99, 084313 (2006).
Dutta, P., Pal, S., Seehra, M. S., Shi, Y., Eyring, E. M. & Ernst, R. D. Concentration of Ce3+ and oxygen vacancies in cerium oxide nanoparticles. Chem. Mater. 18, 5144–5146 (2006).
Deshpande, S., Patil, S., Kuchibhatla, S. V. N. T. & Seal, S. Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide. Appl. Phys. Lett. 87, 133113 (2005).
Kuchma, M. H., Komanski, C. B., Colon, J., Teblum, A., Masunov, A. E., Alvarado, B., Babu, S., Seal, S., Summy, J. & Baker, C. H. Phosphate ester hydrolysis of biologically relevant molecules by cerium oxide nanoparticles. Nanomed. Nanotechnol. 6, 738–744 (2010).
Skorodumova, N. V., Simak, S. I., Lundqvist, B. I., Abrikosov, I. A. & Johansson, B. Quantum origin of the oxygen storage capability of ceria. Phys. Rev. Lett. 89, 166601 (2002).
Romeo, M., Bak, K., Elfallah, J., Lenormand, F. & Hilaire, L. Xps study of the reduction of cerium dioxide. Surf. Interface Anal. 20, 508–512 (1993).
Binet, C., Badri, A. & Lavalley, J. C. A spectroscopic characterization of the reduction of ceria from electronic-transitions of intrinsic point-defects. J. Phys. Chem. 98, 6392–6398 (1994).
Binet, C., Daturi, M. & Lavalley, J. C. IR study of polycrystalline ceria properties in oxidised and reduced states. Catal. Today 50, 207–225 (1999).
Matsumoto, M., Soda, K., Ichikawa, K., Tanaka, S., Taguchi, Y., Jouda, K., Aita, O., Tezuka, Y. & Shin, S. Resonant photoemission-study of CeO2 . Phys. Rev. B 50, 11340–11346 (1994).
Fukui, K., Namai, Y. & Iwasawa, Y. Imaging of surface oxygen atoms and their defect structures on CeO2(111) by noncontact atomic force microscopy. Appl. Surf. Sci. 188, 252–256 (2002).
Namai, Y., Fukui, K. & Iwasawa, Y. Atom-resolved noncontact atomic force microscopic observations of CeO2(111) surfaces with different oxidation states: Surface structure and behavior of surface oxygen atoms. J. Phys. Chem. B 107, 11666–11673 (2003).
Esch, F., Fabris, S., Zhou, L., Montini, T., Africh, C., Fornasiero, P., Comelli, G. & Rosei, R. Electron localization determines defect formation on ceria substrates. Science 309, 752–755 (2005).
Korsvik, C., Patil, S., Seal, S. & Self, W. T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. 1056–1058 (2007).
Pirmohamed, T., Dowding, J. M., Singh, S., Wasserman, B., Heckert, E., Karakoti, A. S., King, J. E. S., Seal, S. & Self, W. T. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem. Commun. 46, 2736–2738 (2010).
Jiao, X., Song, H. J., Zhao, H. H., Bai, W., Zhang, L. C. & Lv, Y. Well-redispersed ceria nanoparticles: promising peroxidase mimetics for H2O2 and glucose detection. Anal. Methods 4, 3261–3267 (2012).
Buettner, G. R. Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agent Med. Chem. 11, 341–346 (2011).
Heckert, E. G., Karakoti, A. S., Seal, S. & Self, W. T. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 29, 2705–2709 (2008).
Nicholls, P. Classical catalase: Ancient and modern. Arch. Biochem. Biophys. 525, 95–101 (2012).
Lipinski, B. Hydroxyl radical and its scavengers in health and disease. Oxid. Med. Cell Longev. 2011, 809696 (2011).
Xue, Y., Luan, Q. F., Yang, D., Yao, X. & Zhou, K. B. Direct evidence for hydroxyl radical scavenging activity of cerium oxide nanoparticles. J. Phys. Chem. C 115, 4433–4438 (2011).
Singh, S., Dosani, T., Karakoti, A. S., Kumar, A., Seal, S. & Self, W. T. A phosphate-dependent shift in redox state of cerium oxide nanoparticles and its effects on catalytic properties. Biomaterials 32, 6745–6753 (2011).
Alili, L., Sack, M., Karakoti, A. S., Teuber, S., Puschmann, K., Hirst, S. M., Reilly, C. M., Zanger, K., Stahl, W., Das, S., Seal, S. & Brenneisen, P. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials 32, 2918–2929 (2011).
Das, M., Patil, S., Bhargava, N., Kang, J. F., Riedel, L. M., Seal, S. & Hickman, J. J. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28, 1918–1925 (2007).
Knott, A. B. & Bossy-Wetzel, E. Nitric oxide in health and disease of the nervous system. Antioxid. Redox Sign. 11, 541–553 (2009).
Martinezarias, A., Soria, J., Conesa, J. C., Seoane, X. L., Arcoya, A. & Cataluna, R. no reaction at surface oxygen vacancies generated in cerium oxide. J. Chem. Soc., Faraday Trans. (1995) 91, 1679–1687.
Dowding, J. M., Dosani, T., Kumar, A., Seal, S. & Self, W. T. Cerium oxide nanoparticles scavenge nitric oxide radical ((NO)-N-center dot. Chem. Commun. 48, 4896–4898 (2012).
Wayland, B. B. & Olson, L. W. Spectroscopic studies and bonding model for nitric oxide complexes of iron porphyrins. J. Am. Chem. Soc. 96, 6037–6041 (1974).
Azevedo, A. M., Martins, V. C., Prazeres, D. M. F., Vojinović, V., Cabral, J. M. S. & Fonseca, L. P. Horseradish peroxidase: a valuable tool in biotechnology In Biotechnology Annual Review ed. El-Gewely R., Ch. 9, 299–332 Elsevier: New York, (2003).
Gao, L. Z., Zhuang, J., Nie, L., Zhang, J. B., Zhang, Y., Gu, N., Wang, T. H., Feng, J., Yang, D. L., Perrett, S. & Yan, X. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat. Nanotechnol. 2, 577–583 (2007).
Song, Y. J., Qu, K. G., Zhao, C., Ren, J. S. & Qu, X. G. Graphene oxide: intrinsic peroxidase catalytic activity and its application to glucose detection. Adv. Mater. 22, 2206–2210 (2010).
Heckert, E. G., Seal, S. & Self, W. T. Fenton-like reaction catalyzed by the rare earth inner transition metal cerium. Environ. Sci. Technol. 42, 5014–5019 (2008).
Lee, H. J., Reimann, J., Huang, Y. F. & Adelroth, P. Functional proton transfer pathways in the heme-copper oxidase superfamily. Biochim. Biophys. Acta 1817, 537–544 (2012).
Peng, Y. F., Chen, X. J., Yi, G. S. & Gao, Z. Q. Mechanism of the oxidation of organic dyes in the presence of nanoceria. Chem. Commun. 47, 2916–2918 (2011).
Di Monte, R. & Kaspar, J. On the role of oxygen storage in three-way catalysis. Top. Catal. 28, 47–57 (2004).
Cohen, P. The origins of protein phosphorylation. Nat. Cell Biol. 4, E127–E130 (2002).
Chin, J. Artificial dinuclear phosphoesterases. Curr. Opin. Chem. Biol. 1, 514–521 (1997).
Franklin, S. J. Lanthanide-mediated DNA hydrolysis. Curr. Opin. Chem. Biol. 5, 201–208 (2001).
Tan, F., Zhang, Y. J., Wang, J. L., Wei, J. Y., Cai, Y. & Qian, X. H. An efficient method for dephosphorylation of phosphopeptides by cerium oxide. J. Mass Spectrom. 43, 628–632 (2008).
Patil, A. J., Kumar, R. K., Barron, N. J. & Mann, S. Cerium oxide nanoparticle-mediated self-assembly of hybrid supramolecular hydrogels. Chem. Commun. 48, 7934–7936 (2012).
Penn, S. G., He, L. & Natan, M. J. Nanoparticles for bioanalysis. Curr. Opin. Chem. Biol. 7, 609–615 (2003).
Xu, C., Liu, Z., Wu, L., Ren, J. & Qu, X. Nucleoside triphosphates as promoters to enhance nanoceria enzyme-like activity and for single-nucleotide polymorphism typing. Adv. Funct. Mater. (2013) doi:10.1002/adfm.201301649.
Guliyev, R., Ozturk, S., Kostereli, Z. & Akkaya, E. U. From virtual to physical: integration of chemical logic gates. Angew. Chem. Int. Ed. 50, 9826–9831 (2011).
Jakupec, M. A., Unfried, P. & Keppler, B. K. Pharmacological properties of cerium compounds. Rev. Physiol. Bioch. P 153, 101–111 (2005).
Gordh, T. & Rydin, H. the question of cerium oxalate as a prophylactic against postoperative vomiting. Anesthesiology 7, 526–535 (1946).
Courtiss, E. H. & Monafo, W. W. Cerium nitrate: a new topical antiseptic for extensive burns. Plast. Reconstr. Surg. 59, 776 (1977).
Biba, F., Groessl, M., Egger, A., Jakupec, M. A. & Keppler, B. K. A novel cytotoxic cerium complex: aquatrichloridobis(1,10-phenanthroline)cerium(III) (KP776). synthesis, characterization, behavior in H2O, binding towards biomolecules, and antiproliferative activity. Chem. Biodivers. 6, 2153–2165 (2009).
Wason, M. S. & Zhao, J. H. Cerium oxide nanoparticles: potential applications for cancer and other diseases. Am. J. Transl. Res. 5, 126–131 (2013).
Apel, K. & Hirt, H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant. Biol. 55, 373–399 (2004).
Mariani, E., Polidori, M. C., Cherubini, A. & Mecocci, P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview. J. Chromatogr. B 827, 65–75 (2005).
Emerit, J., Edeas, M. & Bricaire, F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58, 39–46 (2004).
Pardridge, W. M. Alzheimer’s disease drug development and the problem of the blood-brain barrier. Alzheimers Dement. 5, 427–432 (2009).
Karakoti, A., Singh, S., Dowding, J. M., Seal, S. & Self, W. T. Redox-active radical scavenging nanomaterials. Chem. Soc. Rev. 39, 4422–4432 (2010).
Rzigalinski, B. A. Nanoparticles and cell longevity. Technol. Cancer Res. Treat. 4, 651–659 (2005).
Rzigalinski, B. A., Meehan, K., Davis, R. M., Xu, Y., Miles, W. C. & Cohen, C. A. Radical nanomedicine. Nanomedicine 1, 399–412 (2006).
Schubert, D., Dargusch, R., Raitano, J. & Chan, S. W. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem. Biophys. Res. Commun. 342, 86–91 (2006).
Hickman, J. J., Das, M., Patil, S., Bhargava, N., Kang, J. F., Riedel, L. & Seal, S. Auto-catalytic Ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Tissue Eng. 13, 873–874 (2007).
D’Angelo, B., Santucci, S., Benedetti, E., Di Loreto, S., Phani, R. A., Falone, S., Amicarelli, F., Ceru, M. P. & Cimini, A. Cerium oxide nanoparticles trigger neuronal survival in a human alzheimer disease model by modulating BDNF pathway. Curr. Nanosci. 5, 167–176 (2009).
Geng, J., Li, M., Ren, J., Wang, E. & Qu, X. Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer’s disease. Angew. Chem. Int. Ed. 50, 4184–4188 (2011).
Varadarajan, S., Yatin, S., Aksenova, M. & Butterfield, D. A. Review: Alzheimer’s amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J. Struct. Biol. 130, 184–208 (2000).
Cimini, A., D’Angelo, B., Das, S., Gentile, R., Benedetti, E., Singh, V., Monaco, A. M., Santucci, S. & Seal, S. Antibody-conjugated PEGylated cerium oxide nanoparticles for specific targeting of Aβ aggregates modulate neuronal survival pathways. Acta Biomater. 8, 2056–2067 (2012).
Kim, C. K., Kim, T., Choi, I. Y., Soh, M., Kim, D., Kim, Y. J., Jang, H., Yang, H. S., Kim, J. Y., Park, H. K., Park, S. P., Park, S., Yu, T., Yoon, B. W., Lee, S. H. & Hyeon, T. Ceria nanoparticles that can protect against ischemic stroke. Angew. Chem. Int. Ed. 51, 11039–11043 (2012).
Maritim, A. C., Sanders, R. A. & Watkins, J. B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17, 24–38 (2003).
Pourkhalili, N., Hosseini, A., Nili-Ahmadabadi, A., Hassani, S., Pakzad, M., Baeeri, M., Mohammadirad, A. & Abdollahi, M. Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats. World J. Diabetes 2, 204–210 (2011).
Pourkhalili, N., Hosseini, A., Nili-Ahmadabadi, A., Rahimifard, M., Navaei-Nigjeh, M., Hassani, S., Baeeri, M. & Abdollahi, M. Improvement of isolated rat pancreatic islets function by combination of cerium oxide nanoparticles/sodium selenite through reduction of oxidative stress. Toxicol. Mech. Methods 22, 476–482 (2012).
Sanvicens, N., Gomez-Vicente, V., Masip, I., Messeguer, A. & Cotter, T. G. Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. J. Biol. Chem. 279, 39268–39278 (2004).
Chen, J. P., Patil, S., Seal, S. & McGinnis, J. F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 1, 142–150 (2006).
Kong, L., Cai, X., Zhou, X. H., Wong, L. L., Karakoti, A. S., Seal, S. & McGinnis, J. F. Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. Neurobiol. Dis. 42, 514–523 (2011).
Cai, X., Sezate, S. A., Seal, S. & McGinnis, J. F. Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria. Biomaterials 33, 8771–8781 (2012).
Zhou, X. H., Wong, L. L., Karakoti, A. S., Seal, S. & McGinnis, J. F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the vldlr knockout mouse. PLoS One 6, e16733 (2011).
Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. & Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 121, 2381–2386 (2007).
Lin, W. S., Huang, Y. W., Zhou, X. D. & Ma, Y. F. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int. J. Toxicol. 25, 451–457 (2006).
Ristow, M. Oxidative metabolism in cancer growth. Curr. Opin. Clin. Nutr. Metab. Care 9, 339–345 (2006).
Alili, L., Sack, M., Karakoti, A. S., Teuber, S., Puschmann, K., Hirst, S. M., Reilly, C. M., Zanger, K., Stahl, W., Das, S., Seal, S. & Brenneisen, P. Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor–stroma interactions. Biomaterials 32, 2918–2929 (2011).
Colon, J., Hsieh, N., Ferguson, A., Kupelian, P., Seal, S., Jenkins, D. W. & Baker, C. H. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 6, 698–705 (2010).
Colon, J., Herrera, L., Smith, J., Patil, S., Komanski, C., Kupelian, P., Seal, S., Jenkins, D. W. & Baker, C. H. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine 5, 225–231 (2009).
Tarnuzzer, R. W., Colon, J., Patil, S. & Seal, S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 5, 2573–2577 (2005).
Madero-Visbal, R. A., Alvarado, B. E., Colon, J. F., Baker, C. H., Wason, M. S., Isley, B., Seal, S., Lee, C. M., Das, S. & Manon, R. Harnessing nanoparticles to improve toxicity after head and neck radiation. Nanomedicine 8, 1223–1231 (2012).
Citrin, D., Cotrim, A. P., Hyodo, F., Baum, B. J., Krishna, M. C. & Mitchell, J. B. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 15, 360–371 (2010).
Park, E. J., Choi, J., Park, Y. K. & Park, K. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245, 90–100 (2008).
Hussain, S., Al-Nsour, F., Rice, A. B., Marshburn, J., Yingling, B., Ji, Z. X., Zink, J. I., Walker, N. J. & Garantziotis, S. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano 6, 5820–5829 (2012).
Cheng, G. L., Guo, W., Han, L., Chen, E. L., Kong, L. F., Wang, L. L., Ai, W. C., Song, N. N., Li, H. S. & Chen, H. M. Cerium oxide nanoparticles induce cytotoxicity in human hepatoma SMMC-7721 cells via oxidative stress and the activation of MAPK signaling pathways. Toxicol. In Vitro 27, 1082–1088 (2013).
Asati, A., Santra, S., Kaittanis, C. & Perez, J. M. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 4, 5321–5331 (2010).
Niu, J. L., Azfer, A., Rogers, L. M., Wang, X. H. & Kolattukudy, P. E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res. 73, 549–559 (2007).
Ma, J. Y., Zhao, H. W., Mercer, R. R., Barger, M., Rao, M., Meighan, T., Schwegler-Berry, D., Castranova, V. & Ma, J. K. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology 5, 312–325 (2011).
Ma, J. Y., Mercer, R. R., Barger, M., Schwegler-Berry, D., Scabilloni, J., Ma, J. K. & Castranova, V. Induction of pulmonary fibrosis by cerium oxide nanoparticles. Toxicol. Appl. Pharm. 262, 255–264 (2012).
This work was supported by 973 Project (2011CB936004) and NSFC (21210002, 91213302).
About this article
Cite this article
Xu, C., Qu, X. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Mater 6, e90 (2014). https://doi.org/10.1038/am.2013.88
- Alzheimer’s disease
- cerium oxide nanoparticle
The potential ameliorative impacts of cerium oxide nanoparticles against fipronil-induced hepatic steatosis
Scientific Reports (2021)
Cerium oxide nanoparticles: green synthesis using Banana peel, cytotoxic effect, UV protection and their photocatalytic activity
Bioprocess and Biosystems Engineering (2021)
Scientific Reports (2020)
Fabrication of Ultra-Pure Anisotropic Zinc Oxide Nanoparticles via Simple and Cost-Effective Route: Implications for UTI and EAC Medications
Biological Trace Element Research (2020)
Synthesis and Characterization of Cerium Oxide Quantum Dots Loaded Biodegradable Dextran Matrix for Effective Pain Management
Journal of Cluster Science (2020)